市场调查报告书
商品编码
1119136
全球 CBD 石油和 CBD 消费者健康市场规模研究,按产品(CBD 石油,CBD 消费者健康),按分销渠道(零售,在线,药房),按地区预测 2022-2028Global CBD Oil & CBD Consumer Health Market Size study, by Product (CBD Oil, CBD Consumer Health), By Distribution Channel (Retail Stores, Online, Pharmacies) and Regional Forecasts 2022-2028 |
2021 年全球 CBD 石油和 CBD 消费者健康市场价值约 313.8 亿美元,预计在 2022-2028 年的预测期内以超过 25.60% 的健康增长率增长。
市场增长的一个主要驱动力是大麻二酚 (CBD) 和用于各种药用和保健目的的输液产品的接受度不断提高。此外,有利的政府政策以及由于其健康益处而增加的消费者对大麻二酚的了解和需求正在推动其被接受。此外,CBD 消费者保健产品因其健康益处和缺乏精神作用而广受欢迎。对含大麻二酚产品的健康益处的日益认识增加了渴望购买这些产品的消费者数量。此外,膳食补充剂、止痛药、消耗品、局部用药、油和胶囊等消费品替代品的增加正在推动该行业的发展。公众对大麻二酚 (CBD) 提供的许多健康益处以及大麻二酚油和注入物品的合法性的了解不断增加,正在推动 CBD 作为消费者保健产品的采用并推动市场增长。此外,消费者对基于大麻的大麻二酚产品的态度和看法的变化预计将在整个预测期内促进收入增长。消费者对大麻二酚产品的需求不断增长,包括大麻油、饮料、化妆品和护肤品、胶囊、软糖和狗零食,可能会推动全球 CBD 油和 CBD 消费者健康市场。大麻二酚通过多种方式进入人体,包括进食、吸烟、吸电子烟和皮肤接触。在大麻合法的地方,它用于製备药品和个人护理产品,鼓励业务增长。 CBD 保健品行业日益激烈的竞争给公司带来了推出新产品和扩大地域范围的压力。例如,Aphria Inc. 于 2019 年 4 月进入德国市场,推出了 CannRelief,这是该公司首个基于大麻二酚的膳食补充剂系列。澳大利亚生物製药公司 MGC Pharmaceuticals 于 2019 年 4 月与中国电子商务平台 YuShop Global 合作,进入中国 CBD 保健品市场。这种竞争的加强有望成为市场扩张的动力。然而,草药营养补充剂等替代品的供应将在 2022-2028 年的整个预测期内抑制市场增长。
全球 CBD 石油和 CBD 消费者健康市场研究考虑的主要地区包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 CBD 石油市场由北美主导。推动市场扩张的主要因素是对 CBD 石油的认识不断提高、有利的立法、客户需求的增加以及生产商数量的增加。该地区药用大麻的合法化,尤其是在美国,也促进了 CBD 石油和 CBD 消费者健康市场的兴起。此外,与当地生产商的合作简化了许多组织的供应链管理。他们必须提供符合联邦和州法规的优质大麻。
本报告中包括的主要市场参与者是:
CVS 科学公司
医用大麻公司
夏洛特·韦伯
恩多卡
异地二醇
艾力辛醇
新叶天然有限责任公司
欢乐有机
和美
琼斯勋爵
极光大麻
本研究的目的是确定近年来各个细分市场和国家/地区的市场规模,并预测未来 8 年的价值。该报告旨在包括所涵盖的每个地区和国家的行业的定性和定量方面。此外,它还提供了有关关键方面的详细信息,例如定义市场未来增长的驱动因素和挑战。此外,报告还应详细分析主要参与者的竞争格局和产品供应,以及微观市场中可供利益相关者投资的机会。市场的详细细分和子细分如下所述。
按产品
CBD油
CBD 消费者健康
按分销渠道:
零售商
在线
药房
按地区
北美
美国
加拿大
欧洲
英国
德国
法国
西班牙
意大利
其他欧洲
亚太地区
中国
印度
日本
澳大利亚
韩国
其他亚太地区
拉丁美洲
巴西
墨西哥
世界其他地方
此外,本研究考虑的年份是:
实际年份 - 2018 年、2019 年、2020 年
2021 年基准年
预测期 - 2022 年 至 2028 年
本报告的目标受众是全球 CBD 石油和 CBD 消费者健康市场。
主要咨询公司和顾问
大公司、中型公司、中小企业
风险投资
增值经销商 (VAR)
第三方知识提供者
投资银行家
投资者
Global CBD Oil & CBD Consumer Health Market is valued approximately USD 31.38 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 25.60% over the forecast period 2022-2028. The primary factor driving market expansion is the increase in acceptance of cannabidiol (CBD) and infused products for different medicinal and wellness objectives. Furthermore, favourable government policies, as well as increased consumer knowledge and demand for cannabidiol due to its health advantages, are driving its acceptance. Furthermore, CBD consumer health products are gaining popularity due to their health advantages and lack of psychotropic effects. The growing understanding of the health advantages provided by cannabidiol-infused goods has increased the number of consumers eager to purchase these items. Furthermore, the industry is being driven by an increase in consumer product alternatives such as nutritional supplements, analgesics, consumables, topicals, oils, and capsules. The increased public knowledge of the many health advantages afforded by cannabidiol (CBD), as well as the legality of cannabidiol oil and infused items, are driving CBD's adoption as a consumer health product, resulting in market growth. Additioanally, the shift in consumer attitudes and perceptions toward hemp-derived cannabidiol-based products is likely to increase revenue growth throughout the forecast period. The increased consumer demand for cannabidiol-infused goods such as cannabis oil, beverages, cosmetics and skincare items, capsules, gummies, and dog treats are likely to boost the global CBD Oil And CBD Consumer Health Market. Cannabidiol enters the body via several methods, including eating, smoking, vaping, and skin contact. In places where cannabis is legal, it is being utilized to prepare pharmaceuticals and personal care goods, encouraging business growth. Growing competition in the CBD nutraceuticals industry is putting pressure on firms to introduce new products and expand geographically. Aphria Inc., for example, entered the German market in April 2019 by introducing CannRelief, the company's first cannabidiol-based nutraceuticals product line. MGC Pharmaceuticals, an Australian biopharmaceutical company, partnered with the Chinese e-commerce platform YuShop Global in April 2019 to seek entrance into the Chinese CBD nutraceuticals market. Such increased rivalry is expected to drive market expansion. However, the availability of alternatives such as herbal nutraceuticals stifles market growth throughout the projection period of 2022-2028.
The key regions considered for the Global CBD Oil & CBD Consumer Health Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. The CBD oil market was controlled by North America. The primary drivers driving market expansion include rising CBD oil awareness, favourable laws, increased customer desire, and an increase in the number of producers. The legalisation of medicinal cannabis in the area, particularly in the United States, is also contributing to the rise of the CBD oil and CBD consumer health markets. Furthermore, because of partnerships with local producers, many organisations' supply chain management is simplified. They must provide high-quality cannabis in line with federal and state rules.
Major market player included in this report are:
CVSciences, Inc.
Medical Marijuana, Inc.
CHARLOTTE'S WEB
ENDOCA
Isodiol
Elixinol
NuLeaf Naturals, LLC
JOY Organics
Kazmira
Lord Jones
Aurora Cannabis
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
CBD Oil
CBD Consumer Health
By Distribution Channel:
Retail Stores
Online
Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global CBD Oil & CBD Consumer Health Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
List of figures